Labiana Health SA
MAD:LAB
Operating Margin
Labiana Health SA
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
ES |
L
|
Labiana Health SA
MAD:LAB
|
21.2m EUR |
8%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
831.3B USD |
38%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
373.7B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
48%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
210.9B CHF |
33%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
189.1B CHF |
32%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
163.2B GBP |
23%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
210.3B USD |
35%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
11%
|
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
116.7B EUR |
22%
|
Labiana Health SA
Glance View
Labiana Health SA manufactures sterile and lyophilized dosage forms. The company is headquartered in Pozuelo De Alarcon, Madrid and currently employs 477 full-time employees. The company went IPO on 2022-06-24. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Labiana Health SA's most recent financial statements, the company has Operating Margin of 8.4%.